Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation
Sergio Gutierrez Nunez, Sara Peixoto Rabelo, Nikola Subotic, James Wilson Caruso, Nebojša Nick Knežević · 2025 · 113 citationsRead the paper
Autoimmune diseases are chronic inflammatory conditions characterized by the breakdown of immune tolerance to self-antigens. While genetic and environmental factors play key roles, growing evidence highlights chronic stress as a significant contributor to immune dysregulation through its impact on the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis, primarily via cortisol secretion, serves as the major neuroendocrine mediator of stress responses, influencing both immune regulation and systemic homeostasis. This review synthesizes current literature on HPA axis physiology, the mechanisms of cortisol signaling, and the maladaptive effects of chronic stress. Emphasis is placed on clinical and experimental findings linking HPA dysfunction to immune imbalance and autoimmunity, as well as organ-specific consequences across neuroimmune, endocrine, cardiovascular, gastrointestinal, integumentary, and musculoskeletal systems. Chronic stress leads to impaired HPA axis feedback, glucocorticoid receptor resistance, and paradoxical cortisol dysregulation, fostering a pro-inflammatory state. This dysregulation promotes cytokine imbalance, weakens protective immune mechanisms, and shifts the immune response toward autoimmunity. Evidence from both human and animal studies associates persistent HPA dysfunction with diseases such as systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis. HPA axis dysregulation under chronic stress constitutes a critical mechanistic link between psychological stress and autoimmune disease. Understanding these pathways provides opportunities for therapeutic interventions, including stress management, lifestyle modification, and neuroendocrine-targeted treatments. Future research should focus on multi-omics and longitudinal approaches to clarify the reversibility of HPA alterations and identify resilience factors.
What the full text shows
Shown in the lab- Chronic stress-related HPA axis dysregulation is linked to increased risk of autoimmune thyroid disease and rheumatoid arthritis. — Hazard ratios from 1.09 (RA) to 1.49 (autoimmune thyroid disease) (Population-based and sibling comparison designs)
- Chronic psychological stress impairs the ability of dexamethasone to suppress IL-6 production. — Significantly reduced suppression vs. healthy controls (Parents of cancer patients)
- Chronic HPA dysregulation shifts the cytokine network toward a pro-inflammatory state. — Increased IL-6, TNF-α, and IL-17; decreased IL-10 (Chronic stress/glucocorticoid receptor resistance)
- Genetic variants in PTPN22 (620 V) correlate positively with SLE, RA, T1DM, and Hashimoto’s thyroiditis, but negatively with multiple sclerosis. (Human clinical/population studies)
- Genome-wide association studies identified susceptibility loci for inflammatory bowel diseases. — 99 loci total (71 for Crohn’s, 47 for ulcerative colitis) (GWAS data)
- Setup
- Multi-study synthesis including GWAS, sibling comparison designs, and pilot RCTs.
- How
- Literature review synthesizing clinical and experimental findings from human population studies, animal models (e.g., MRL-lpr mice), and randomized controlled trials.
- Limitations
- Lack of high-quality studies in low-resource settings · Limited evidence for genetic components beyond HLA and PD-1/PTPN22 · Unclear temporal dynamics of glucocorticoid resistance
Summarized by Gemma 4 from the open-access full text · 12 Oct 2026. Read it